INTRODUCTION T
HE COMPLEMENT SYSTEM plays an important role in innate immunity and consists of three pathways: the classical, the alternative, and the lectin pathway. (1, 2) The lectin complement pathway is activated by mannose-binding lectin (MBL) binding (3) and activation of two C1s/C1r-like serine proteases, MBL associated serine proteinases (MASPs), which cleave C2 and C4 to form the classical C3 convertase. (4) (5) (6) MBL is a calciumdependent C-type lectin and its binding has specificity for mannose and N-acetyl-D-b-glucosamine (GlcNAc). (3) MBL is structurally similar to C1q and forms homo-oligomeric structures of 32-kDa trimeric subunits. (7) Each subunit contains an N-terminal region, a collagen-like region, a a-helical coiled-coil neck region and a C-terminal carbohydrate recognition domain (CRD), which assembles in a carboxy-to amino-terminal direction. (8) (9) (10) Trimerization of the a-helical coiled-coil region enables the formation of the collagen triple helical conformation. (11) We have previously demonstrated that the lectin pathway is activated on human endothelial cells after oxidative stress. (12) Recent studies also suggest that the lectin pathway may cause glomerular injury in nephritis. (13) (14) (15) Inhibition of rat MBL-A significantly reduces myocardial ischemia and reperfusion injury, demonstrating a novel pro-inflammatory role of the lectin pathway in vivo. (16) Inhibition of MBL attenuates polymorphonuclear leukocyte (PMN) adherence and chemotaxis and reduces proinflammatory gene expression in vivo and in vitro suggesting that the lectin pathway maybe a therapeutic target for inflammatory conditions. (17, 18) A panel of novel monoclonal antibodies (MAbs) against human MBL attenuates MBL-dependent complement activation. (12) Characterization of these functionally inhibitory antibodies and identifying the MBL recognition sites may aid in understanding the role of MBL in inflammation and in the development of additional potent inhibitors. Thus, we further characterized the interactions of these MAbs and their Fab fragments to MBL.
MATERIALS AND METHODS

Materials
All surface plasmon resonance (SPR) experiments were performed on a BIAcore 3000 (BIAcore AB, Uppsala, Sweden). The BIAcore reagents for the interaction analysis including the C1 sensor chip, N-hydroxysuccinimide (NHS), N-ethyl-N9-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC), 1 mol/L ethanolamine, pH 8.5, were obtained from Pharmacia Biosensor AB (Uppsala, Sweden). All other chemicals and reagents were from Sigma (St. Louis, MO), unless mentioned in the text. Full-length and truncated recombinant MBL was produced in Chinese hamster ovary (CHO) cells and E. coli cells, respectively, as described previously. (19, 20) 
Generation of MAbs and their Fab and F(ab) 2 fragments
MAbs were generated as previously described. (12) Clones were grown in tissue culture and MAbs purified by protein G chromatography. (12) Purified MAbs were incubated with papain (1:25) in digestion buffer (20 mmol/L ethylene-diaminetetraacetic acid [EDTA] disodium, 20 mmol/L L-cysteine in phosphate-buffered saline [PBS]) at 37°C for 16 h to generate Fab fragments. The reaction was terminated by addition of 5.55 mg/mL iodoacetamide. Purified MAbs were incubated with pepsin (1:20) in 200 mmol/L sodium acetate buffer (pH 4.0) at 37°C for 6 h to make F(ab) 2 fragments. Tris base (400 mmol/L) was used to stop this reaction. The cleaved antibodies were dialyzed against PBS at 4°C for 16 h and then loaded onto a protein G column, preconditioned with PBS-EDTA-NaCl (10 mmol/L EDTA disodium, 750 mmol/L NaCl in PBS), to remove Fc fragments and non-digested whole antibodies. Fab or F(ab) 2 fragments were collected, concentrated, and analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie staining.
Interaction of MBL with MAb 2A9 and its Fab fragment
SPR was used to detect the interaction of MAbs or their Fab fragments to full-length recombinant MBL (rMBL). The running buffer consisted of 10 mmol/L HEPES, 150 mmol/L NaCl, 40 mmol/L CaCl 2 and 40 mmol/L MgCl 2 , pH 7.4. The pioneer C1 sensor chip (containing no dextran) was cleaned by the injection of 0.1 mol/L glycine-NaOH, pH 12 containing 0.3% Triton X-100 at a flow rate of 25 mL/min. rMBL [1000 Resonance Units (RU)] was immobilized by amine coupling according to the manufacturer's instructions (BIAcore, Uppsala, Sweden). The control flow cell was treated the same way, except no rMBL was included in the coupling reaction. To eliminate nonspecific binding and bulk changes in the refractive index, the surfaces (experimental and control) were further blocked three times with 5 min injections of 100 mg/mL bovine serum albumin (BSA) at 5 mL/min.
The interaction of MAbs or Fab fragments with a series of rMBL concentrations was analyzed by a 3-min contact time at a flow rate of 25 mL/min and 5 min of dissociation time. The sensor surface was regenerated by a 30-sec injection of 100 mmol/L glycine-HCl, pH 3.0 at a flow rate of 50 mL/min. Each sensorgram represents the relative response after subtraction of the control flow cell. The data analysis was performed using the BIA evaluation 3.1 software package (BIAcore AB, Uppsala, Sweden). The kinetic parameters [i.e., association rate constant (k a ), dissociation rate constant (k d ), and affinity constant (K D )] were obtained from global fitting.
Inhibition of C3 deposition on mannan-coated plates
MBL-dependent C3 deposition on mannan-coated plates was performed as previously described. (12, 21) Human sera (HS; 2%) preincubated with (a) vehicle [veronal buffered saline (VBS) containing 10 mmol/L Ca 21 /Mg 21 ]; (b) GlcNAc (100 mmol/L); (c) MAb 2A9 or 3F8 (10 mg/mL); (d) Fab fragments of MAb 2A9 or 3F8 at various concentrations (1 mg/mL, 10 mg/mL, or 100 mg/mL); (e) F(ab) 2 fragments of MAb 2A9 at various concentrations (1 mg/mL, 10 mg/mL, or 100 mg/mL); (f) 10 mg/mL MAb 2A9 Fab plus goat-anti-mouse F(ab) 2 fragments (1 mg/mL, 10 mg/mL, or 100 mg/mL); or (g) goat-anti-mouse F(ab) 2 fragments (100 mg/mL) at 25°C for 30 in were added to the mannan coated plates and then incubated at 37°C for 30 min. The relative amounts of C3 deposition on the wells were detected with an horseradish peroxidase (HRP)-conjugated goat anti-human C3 polyclonal antibody (1:2000; ICN, Aurora, OH). Inhibition of C3 deposition by MAbs or their Fab fragments was determined to be the amount of C3 deposited relative to inhibition by 100 mmol/L GlcNAc (i.e., 100%). C3 deposition was evaluated using four wells per experimental group and each experiment was repeated three times (n 5 3). Data analyses were performed using Sigma Stat (Jandel Scientific, San Rafeal, CA) and a p value of ,0.05 was considered significant. The data represent the mean and SEM for n determinations.
Enzymatic digestion of rMBL with trypsin and electroblotting for sequencing
Full-length rMBL (70 mg) was digested using trypsin (1:5) in 100 mmol/L Tris-HCl buffer, pH8.5 at 37°C for 18 h. The proteolytic digested material was then run on a 16.5% SDS-PAGE tricine gel and electro-transferred to polyvinylidene difluoride (PVDF) membrane. The membrane was washed; stained with 0.5% Ponceau S; and the smallest proteolytic fragment (14 kDa), which reacted with MAb 2A9 from Western analysis, was excised. The sample was then sequenced by Edman degradation (Harvard Microchemistry Facility, Harvard University).
Construction and expression of C-terminal deletions of a truncated rMBL (trMBL)
A cDNA fragment of trMBL, containing the neck region and the CRD region of human MBL was used to generate sequential C-and N-terminal deletion constructs of trMBL by polymerase chain reaction (PCR). (20) A forward primer for trMBL (59-GGGCTCG AGGGAGAC CCTGGAAAAAGTCCG -39) and four reverse primers (trMBL-1: 59-GGGGAATTCTC-ATTCATCAGAACCAGCA TTGTT-39; trMBL-2: 59-GGG-GAATTCTCACAGTAGCAATACACAATCTTC-3 9; trMBL-39;59-GGGGAATTCTCAGT CATTCCACTGGCCATTTT T-39; and trMBL-4: 59-GGGGAATTCTCAATGGGAGGTG-GAGCAGGGGAC-39) were used to generate C-terminal dele-tion constructs. A reverse primer 59-GGG-GAATTCT-CAGATAGGGAACTCACAGAC-3 9 and three forward primers (trMBL-N1: 59-GGGCTCGAGATGGCACGTATCA-AAAAGTGG-39; trMBL-N2: 59-GGGCTCGAGGGCAAAC-AAGTTGGGAACAAG-3 9; and trMBL-N3: 59-GGG-CTC-GAGTTCTTCCTGACCAATGGTGAA-3 9) were used to generate N-terminal deletion constructs. EcoRI and XhoI restriction sites were flanked on the side of each of the primers and a stop codon was added before the restriction site on each of the reverse primers. The PCR products were further digested with EcoRI and XhoI, cloned into a bacterial vector pRSET-A (Invitrogen Co., San Diego, CA), predigested with EcoRI and XhoI, and transformed into BL21(DE3) pLysS cells for protein expression.
Single colonies of the transformed cells were inoculated into 10 mL of SOB medium (2% Bacto-tryptone, 0.5% Bacto-yeast extract, 0.05% NaCl, 2.5 mmol/L KCl, 10 mmol/L MgCl 2 , 100 mg/mL ampicillin and 35 mg/mL chloramphenicol) and grown overnight at 37°C. The overnight cultures were diluted in 100 mL SOB medium and grown until optical density (OD) 600 reached 0.3. The cells were further induced by isopropyl-b-thiogalactopyranoside (IPTG) (1 mmol/L) for 3 h. The cells were then harvested by centrifugation at 5,000 g at 4°C for 15 min and resuspended in 5 mL of denaturing buffer [TBS with calcium (TBS/C; 20 mmol/L Tris-HCl, 500 mmol/L NaCl, 5 mmol/L CaCl 2 , pH 7.4) containing 6 mol/L urea]. After sonication on ice, the bacterial lysates were removed by centrifugation at 10,000 g at 4°C for 20 min. The cell supernatants were applied to prepacked His-Trap nickel chelating columns (Amersham Pharmacia Biotech AB, Uppsala Sweden), equilibrated with the start buffer (denaturing buffer 1 10 mmol/L imidazole). The columns were washed with start buffer and Histagged proteins were then eluted (denaturing buffer 1 500 mmol/L imidazole]. The peptides were sequentially dialyzed against TBS/C with 1 mol/L urea and 0.5 mol/L urea and TBS/C. (20) Western analysis of mutation constructs of trMBL Deletion constructs of trMBL were resolved by 16.5% SDS-PAGE. The gels were then transferred to nitrocellulose and blocked with 10% nonfat dry milk in phosphate-buffered salinetween/bovine serum albumin (PBST/BSA) buffer (PBS, 0.1% Tween 20, 0.1% BSA, pH 7.4) at 4°C overnight. The nitrocellulose was incubated with MAbs (10 mg/mL) or HRP-conjugated pAb R2.2 (1:1000; pAb against human MBL) in PBS-TB buffer at 25°C for 1 h. The nitrocellulose was then washed and the MAb bound membrane was detected with HRP-conjugated goat anti-mouse polyclonal antibody (1:5000, ICN, Aurora, OH) at 25°C for 1 h. The nitrocellulose was then washed and developed with the enhanced chemiluminescence (ECL) supersignal system (Pierce, Rockford, IL) and autoradiographic films (Kodak).
Flitrix random peptide display library and western analysis of thioredoxin-flagellin fusion proteins containing peptides
The Flitrix system uses bacterial flagellar protein (FliC) and thioredoxin (TrxA) to display random peptides on the cell surface of E. coli. (22) The panning methods using Flitrix random peptide library containing 1.77 3 10 8 primary clones with insertion of different 10 mer or 12 mer peptides (Invitrogen Inc.) were done as described in the manufacturer's protocol and by Lu et al. (22) The Flitrix peptide library was grown in IMC medium (0.2% casamino acids, 0.5% glucose, 0.6% Na 2 HPO 4 , 0.3% KH 2 PO 4 , 0.05% NaCl and 0.1% NH 4 Cl, 1 mmol/L MgCl 2 , pH 7.4, and 100 mg/mL ampicillin) at 25°C for 15 h. Thioredoxin-flagellin fusion proteins containing the peptides were then induced by tryptophan (100 mg/mL) in IMC medium at 25°C for 6 hours. mAbs (2A9 or 3F8; 25 mg/mL) were coated on 60-mm Petri plates and blocked with IMC medium, containing 1% nonfat dry milk, 1% a-methylmannoside, 150 mmol/L NaCl. The 6 hour-induced cells (10 ml) were then added to the Petri plate coated with mAbs and incubated at 25°C for 1 hour. The unbound bacterial cells were removed by washing the Petri dish 5 times with IMC medium containing 1% amethylmannoside. The bacteria bound to the antibody were detached by vortexing and eluted with 10 mL of IMC medium. The eluted cells were grown at 25°C for 15 h and used for the next round of biopanning. After 10 rounds of biopanning, the cells were plated and individual colonies were picked for plasmid isolation and induced by tryptophan for protein expression. The plasmids from the positive clones containing the peptides that reacted with MAb 2A9 or 3F8 were isolated and sequenced.
Inhibition of MAb 2A9 interaction with MBL with an MBL peptide or Flitrix peptide
A peptide derivative of MBL (KKSDEDCVLLLKNG-WNDVPCS); peptide derived from Flitrix biopanning (i.e., VTILQPSYTEDS) or a control peptide (i.e., GGFGSGG-GGFGGGGFGGGGYGGGYG) were synthesized and purified by high-performance liquid chromatography (HPLC) (Princeton Biomolecules). These peptides were used to inhibit the interaction of MAb 2A9 to rMBL as detected by SPR. Ten mmol/L of 2A9 was pre-incubated with 100 mmol/L of each peptide (MBL, Flitrix or control) for 1 h and then injected on the sensor surface immobilized with rMBL and analyzed as described above.
3-D Modeling of peptides and energy minimization
Three-dimensional (3D) models of the peptides biopanned from Flitrix peptide library using MAbs and a peptide derivative from MBL were built using Sculpt (MDL Information Systems, Inc, San Leandro, CA). The Sculpt modeling program was used further to refine the conformation and to minimize the energy of the peptides due to van der Waals, torsion, hydrogen bonds, and electrostatic interactions. (23) The Flitrix 3F8 peptide was aligned and superimposed with the known 3D MBL monomeric structure (Downloaded from PDB data bank) using Sculpt.
RESULTS
Interaction of MAbs or their Fab fragments to rMBL
SPR was used to characterize the interactions of functional MAbs or their Fab fragments to rMBL immobilized to the sensor surface. Representative sensorgrams for the interactions of
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2A9 MAb or its Fab fragments at different concentrations to immobilized rMBL are shown in Fig. 1 . Similar results were observed with 3F8 (data not shown). Whole MAbs or their Fab fragments bound to rMBL with a relative high affinity. The individual kinetic profiles of each MAb or its Fab fragments are summarized in Table 1 . Fab generation of MAb did not abolish its ability to bind rMBL, although the affinities of the interactions were reduced approximately 10-fold (Table 1) . Interestingly, calcium played an important role for the interaction of MAb to MBL, which is similar to the binding of MBL to its own ligands. (21, 24) Addition of EDTA (10 mmol/L) to the running buffer eliminated the interactions of all the MAbs or their Fab fragments to rMBL as shown in Fig. 1 . Because calcium ion (Ca 21 ) is important for stabilizing the conformation of MBL, the interaction of MBL with MAbs or Fab fragments may be dependent on the conformation of MBL.
Inhibition of complement activation by Fab or F(ab) 2 fragments of MAbs
The ability of anti-MBL MAbs or their fragments to inhibit activation of the lectin complement pathway was evaluated as previously described. (12) Inhibition of C3 deposition by 100 mmol/L of GlcNAc relative to vehicle was considered to be 100% inhibition ( Fig. 2A and 2B) . (12) As we have shown previously, MAbs 2A9 and 3F8 (i.e., whole antibody) significantly inhibited C3 deposition on mannan-coated plates at a concentration of 10 mg/mL ( Fig. 2A and 2B ). (12) Fab fragments of 3F8 inhibited C3 deposition in a dose-dependent manner. However, 2A9 Fab fragments did not show any inhibition at any concentration ( Fig. 2A) . F(ab) 2 fragments of 2A9 partially inhibit C3 deposition, but only at a concentration of 100 mg/mL ( 
To test if inhibition MBL by MAb 2A9 was related to steric hindrance, we attempted to reconstitute the "bulky" nature of a MAb by incubating 2A9 Fab fragments with goat anti-mouse F(ab) 2 fragments (Fig. 2B) . Goat anti-mouse F(ab) 2 fragments (100 mg/mL) alone did not inhibit C3 deposition (Fig. 2B) . Enlarging the size of the 2A9 Fab fragment with the addition of goat anti-mouse F(ab) 2 fragments increased the inhibitory potential of 2A9 Fab fragments. These data demonstrate that even though whole IgG of both antibodies are functionally active, MAb 3F8 inhibits complement activation by Fab fragment, while inhibition of MBL with MAb 2A9 occurred via steric hindrance. MAb hMBL1.2 had similar inhibitory ability as that of 2A9 (data not shown). We, therefore, focused the rest of the characterization on MAb 3F8 and 2A9.
MAbs recognize the CRD region of MBL
In order to further identify which region within MBL the MAbs recognized, we trypsinized rMBL. A 14-kDa peptide was the smallest rMBL fragment recognized by MAb 2A9 under nonreduced conditions (Fig. 3) . MAbs weakly recognized this peptide under reduced condition (data not shown). N-terminus protein sequencing (Edman degradation) demonstrated that this peptide was contained in the CRD region of MBL, indicating that this MAb recognized an epitope in the CRD.
DCVLLL in the CRD region of MBL functioned as part of the epitope for MAb 2A9 binding and MAb 3F8 recognized the hinge region of MBL
To further localize the epitopes for the MAbs, a truncated form of MBL (trMBL) was used to generate sequential N-and C-terminal deletion constructs by PCR (Fig. 4A ). This form of trMBL contains a short collagen region, the neck region, and the CRD region of MBL. (20) The deletion constructs were expressed in the same system as that of trMBL. A polyclonal antibody against MBL, R2.2, recognized all the deletion constructs (trMBL C1 to C4 and trMBL N1 to N3), indicating that N-or C-terminal deletions did not affect expression of the proteins in the constructs (Fig. 4C and 4E ). Western analysis showed that MAb 2A9 recognized all the N-terminal deletion constructs (trMBLN1-N3) and all the C-deletion constructs (e.g., trMBL C2, C3, and C4) except trMBLC1, which had six additional residues, DCVLLL, removed from trMBLC2, indicating these six residues are important for 2A9 recognition (Fig.  4B) . MAb 3F8 recognized trMBL but none of the C-terminal deletion constructs, indicating residues LAVCEFPI may play a role for 3F8 recognition. In addition, MAb 3F8 recognized only trMBLN1, but not trMBLN2, indicating that residues MARIKKWLTFSL may also be important for MAb 3F8 recognition. These two peptide sequences are located in close proximity in the native conformation of MBL and form the hinge within the CRD region of MBL. Thus, MAb 3F8 may recognize a discontinuous epitope within this region.
Biopanning MAbs using Flitrix random peptide display library
To map further the MBL epitopes recognized by 2A9 and 3F8, peptides (13 mers) with three amino acid overlapping sequences derived from MBL were synthesized on continuous cellulose membranes by the spot technique and used to identify residues recognized by MAbs using Western analysis. None of the linear peptides were recognized (data not shown) by either 3F8 or 2A9, indicating that the MBL recognition was conformation dependent.
A Flitrix random peptide display library was used next to further define the conformational dependent MBL epitopes. (22) The Flitrix random library contains 1.77 3 10 8 primary clones and each clone displays a peptide having a well-defined structure constrained into an active loop of thioredoxin, which is fused into the major flagellin proteins expressed on the surface of E. coli. After biopanning, expression of the Flitrix peptide fusion proteins (63 kDa) was checked by Coomassie staining and positive clones consisted of those 63-kDa fusion proteins that reacted with the MAbs by Western analysis. After 10 rounds of biopanning, positive colonies were picked, induced by tryptophan, and cellular lysates were run on SDS-PAGE. A representative Coomassie blue staining of fusion proteins (63 kDa; Fig. 5A ) and duplicate samples following Western analysis with MAb 2A9 (Fig. 5B) 
Conformation dependent recognition of MBL by MAb 2A9
Molecular models of the 2A9 positive Flitrix peptide, VTILQPSYTEDS, and the representative MBL sequence ED-CVLLL, identified by deletion constructs of trMBL (Fig. 4A  and 4B ) were generated and their energies minimized using Sculpt ( Fig. 6A and 6B ). The peptides had similar "cleft" conformation, where the solvent accessibility and polarities of residues highlighted in red in Fig. 6A were similar (Fig. 6B) . This "cleft" structure is a part of the b-sheet present within the 3D model of MBL, in which the secondary structure motifs were color-coded (e.g., helix 5 green, b-strand 5 orange, and turns and random structures 5 cyan; Fig. 7A and 7B) . (25) A peptide derivative of MBL (KKSDEDCVLLLKNG-WNDVPCS), the peptide derived from Flitrix biopanning (VTILQPSYTEDS), and a control peptide (GGFGSGGG-GFGGGGFGGGGYGGGYG) were synthesized. These peptides were used to inhibit the interaction of MAb 2A9 to rMBL immobilized on a BIAcore sensor chip. Preincubation of MAb 2A9 with the Flitrix peptide or the MBL peptide (MAb to peptide: 1:10 molar ratio) resulted in a loss 2A9 binding by approximately 75 and 50%, respectively (Fig. 6C) . Incubation of MAb 2A9 with the control peptide did not attenuate the 2A9 binding to rMBL (Fig. 6C) . Thus, the Flitrix peptide or the MBL peptide interacted with mAb 2A9 prevented its interaction with rMBL.
Conformation dependent recognition of MBL by MAb 3F8
A molecular model of the 3F8 positive Flitrix peptide was generated and its energy minimized by Sculpt (purple in Fig.  7B ). To identify the MBL sequence that closely mimicked the 3F8 Flitrix peptide, the molecular model for the peptide was overlaid on an MBL model containing mainly the MBL CRD region (Fig. 7B) . Interestingly, the peptide overlapped to the hinge region of MBL. This model supports the data obtained using deletion constructs (Fig. 4A and 4D ) that MAb 3F8 recognized a discontinuous epitope located in the hinge region. These data also support the hypothesis that the recognition epitope of 3F8 is likely dependent upon the conformation of the epitope.
DISCUSSION
Complement activation plays important roles in the pathogenesis of cardiovascular injury after oxidative stress. (26) (27) (28) (29) We have previously demonstrated that the lectin complement pathway, initiated by MBL binding, is activated on the vascular endothelium following oxidative stress. (12) Recently we also demonstrated that lectin pathway activation induces pro-inflammatory gene expression and tissue injury after myocardial ischemia and reperfusion (MI/R) in vivo. (16) To inhibit MBL binding or lectin pathway activation, therapeutic interruption of MBL binding or activation of the lectin pathway is needed. We have recently developed a panel of novel MAbs that functionally inhibit MBL binding. (12) To have a better understanding of the mechanism by which MAbs inhibit MBL binding, we characterized of the interaction of these MAbs to MBL, identified their recognition sites, and further investigated the structural and functional relationship of these epitopes.
The interactions of MAb 2A9 and its Fab fragment to MBL were characterized using SPR. Whole MAb or its Fab fragment bound to rMBL with relative high affinities as summarized in Table 1 . Functional analysis of MAb 2A9 and its Fab fragments demonstrated that it inhibited complement activation only as a F(ab) 2 fragment, or following the addition of "bulky" F(ab) 2 fragments to its Fab fragments (Fig. 2B) . Thus, these data support the concept that steric hindrance induced by 2A9 binding is important for its inactivation of MBL binding. MAb 3F8, however, inhibited complement activation by its Fab fragment ( Fig. 2A) . Thus, MAb 3F8 and 2A9 inhibited complement activation differently, although they share a common characteristic of being functional inhibitors of MBL.
To identify further the recognition sites for these mAbs, we trypsinized full-length rMBL. Western analysis demonstrated that a 14-kDa peptide, containing mainly the CRD region of MBL was the smallest fragment recognized by 2A9 under nonreduced conditions (Fig. 3) . The antibody recognized the same peptide weakly under reduced condition (data not shown), suggesting that MBL recognition by 2A9 was dependent on the conformation of the MBL epitope. We have previously demonstrated that MAb 3F8 is a poor MAb to use for Western analysis, suggesting that its epitope is discontinuous, thus we did not attempt to immunoblot trypsinized MBL with 3F8. (12) A trMBL, containing a short collagen region, the neck region and the CRD region was used to generate a series of carboxy-terminal and amino-terminal deletion constructs and to identify further MAb epitopes. The deletion study showed that DCVLLL was essential for MAb 2A9 binding (Fig. 4B and  4C ). The deletion study also showed that MAb 3F8 did not recognize the same epitope as 2A9. The 3F8 epitope was likely to be discontinuous and located in the hinge region in MBL because removing a peptide sequence on either side of the hinge region (e.g., LAVCEFPI or MARIKKWLTFSL) abolished the binding ability of mAb 3F8 to MBL (Fig. 4E and  4F) .
The Flitrix peptide library was further used to confirm and refine the identification of MBL epitopes for these MAbs. A single peptide, VTILQPSYTEDS, was identified from the library as an epitope for 2A9. We then compared the identified Flitrix peptide sequence with those residues important for 2A9 binding identified from the deletion construct studies. Residues VTIL in the Flitrix peptide are similar to VLLL residues from MBL ( Fig. 6A ) because they both have the residues V-L; and amino acids TI and LL are similar in size and polarity. Because there are no cysteines in the peptide library and serine has similar size and polarity as cysteine, EDS is a good match for EDC in EDCVLLL in MBL, in which the amino acid E was added to the peptide identified from deletion study (Fig. 6A) . In addition, the peptide from the Flitrix library forms a similar conformation as that of EDCVLLL by 3D modeling and energy minimization, especially the cleft region, presumably the epitope of MAb 2A9, where VLLL (or VTIL) and EDS are held closely in space ( Figure 6B in the Flitrix peptide, thus helps hold VTIL and EDS in close proximity, and which forms a similar epitope as that in the native MBL protein (Fig. 7) . Therefore, formation of a specific conformation of the MBL epitope is essential for 2A9 binding.
An x-ray structure of a human MBL fragment, containing amino acids 108 to 248, was downloaded from the National Library of Medicine (PDBID #1HUP) (25) (Fig. 7A) . A molecular model of this MBL fragment was generated in RasMol with the recognition site EDCVLLL for MAb 2A9 binding highlighted in red (Fig. 7B) . EDCVLLL forms a b-sheet in MBL based on x-ray structural analysis. (25, 30) Four calcium ions (red balls in Fig. 7A ), especially the second calcium from the left, are critical for stabilizing the conformation of MBL, thus, aids in MBL binding to its substrate, mannose (a butterfly structure in Fig.  7A ). (25, 31) Two carboxylate oxygen atoms of Glu 220 (E) in EDCVLLL are responsible for interacting with two of these calcium ions. (25, 31) Further, Asp 221 (D) interacts with the second calcium ion next to mannose, which aids in the binding of MBL to mannose. (25, 31) The binding of whole 2A9, but not Fab fragments, to residues Glu 220 and Asp 221 would clearly block the MBL binding to mannose by producing a structure that sterically hinders MBL binding to mannose. Hydrophobic branches in VLLL residues and the hydrophobic side chain of ED residues in EDCVLLL are likely responsible for stabilizing the b-sheet conformation of EDCVLLL. Further, functional analysis using the peptides obtained from Flitrix system and the peptide derived from MBL containing EDCVLLL with preservation of a b-sheet conformation in solution supports the assumption for the requirement of a b-sheet conformation for mAb 2A9 recognition (Fig. 6C) .
A molecular model of the Flitrix peptide recognized by MAb 3F8 was generated by 3D modeling and energy minimization. We used SCULPT to overlay this Flitrix peptide onto MBL (purple in Fig. 7B ). The peptide overlapped in the MBL hinge region, which was also identified important for MAb 3F8 binding from our deletion construct studies (Fig. 7B) . Inhibition of MBL binding by MAb 3F8 is most likely due to its binding to a discontinuous epitope located in the hinge region of MBL, which induces a conformation change in MBL. This assumption is further supported by the observation that 3F8 Fab fragments functionally inhibit MBL. Thus, 3F8 binding to the MBL hinge region may induce an overall conformation change within MBL to disrupt its ability to bind to its substrates.
In summary, we identified the functional epitopes of anti-MBL MAbs to the CRD region of MBL. Structural and functional characterization of MAb 2A9 suggested that it inhibited MBL by steric hindrance, while MAb 3F8 likely inhibits MBL binding by inducing a conformational change in MBL. 3F8 Fab fragments are functionally inhibitory and suggest that recombinant scFv fragments could be generated in culture that would inhibit MBL binding. MBL recognition by the MAbs was dependent on the conformation of the epitopes. The interaction of the anti-MBL MAbs was of higher affinity (i.e., K D of ,10 29 M) than that of monosaccharides (e.g., K D of 10 23 ), (32) but within a similar range as polysaccharides (e.g., K D of 10 29 ). (33) These data demonstrate that MBL binding can be inhibited by at least two separate independent mechanisms and that at least two different, functionally important epitopes are available for MAb design.
